Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin beta-13 is a calcium-dependent cell-adhesion protein encoded by the PCDHB13 gene, part of a large clustered gene family located on human chromosome 5. It is an integral plasma membrane protein with six extracellular cadherin domains, deviating structurally from other cadherins, and a singular cytoplasmic tail. Its primary biological role is thought to be the homophilic interaction among cells to establish and maintain specific neural connections, contributing to neuronal circuit formation in the brain. The biological mechanism involves both EC domain structure diversity and strict interface specificity, ensuring highly selective cell surface recognition in the nervous system. While PCDHB13 may be associated with neurodevelopmental conditions and alterations in certain cancers, it is not currently recognized as a therapeutic target, and its exact functional roles in health and disease remain under investigation
None known for drug-target interactions; functional mechanism relates to homophilic binding and cell-cell adhesion via extracellular cadherin domains, important for neuronal circuit assembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin beta-13 (PCDHB13).